GABIL?
Product Description
Biocon Limited
-
IN
-
2015On CPHI since
-
2Certificates
-
5000+Employees
Company types
Primary activities
Categories
Specifications
Biocon Limited
-
IN
-
2015On CPHI since
-
2Certificates
-
5000+Employees
Company types
Primary activities
More Products from Biocon Limited (99)
-
Product FERVAY-250?
Biocon offers a wide range of comprehensive care which includes fervay-250?. Composition: each film coated tablet contains: cefuroxime axetil ip, equivalent to cefuroxime 250 mg. Mechanism of action: cefuroxime inhibits bacterial cell wall synthesis by binding to one or more of the penicillin-binding prote... -
Product FERVAY-500?
Biocon offers a wide range of comprehensive care which includes fervay-500?. Composition: each film coated tablet contains: cefuroxime axetil ip, equivalent to cefuroxime 500 mg. Mechanism of action: cefuroxime inhibits bacterial cell wall synthesis by binding to one or more of the penicillin-binding prote... -
Product FERVAY? 1.5 g
Biocon offers a wide range of comprehensive care which includes fervay 1.5 g. Composition: each vial contains: sterile cefuroxime sodium ip, eq. To cefuroxime 1.5 g. Mechanism of action: cefuroxime inhibits bacterial cell wall synthesis by binding to one or more of the penicillin-binding proteins (pbp?s). ... -
Product FERVAY? 750 mg
Biocon offers a wide range of comprehensive care which includes fervay 750 mg. Composition: each vial contains: sterile cefuroxime sodium ip, eq. To cefuroxime 750 mg. Mechanism of action: cefuroxime inhibits bacterial cell wall synthesis by binding to one or more of the penicillin-binding proteins (pbp?s)... -
Product FEVEIN?
Biocon offers a wide range of nephrology which includes fevein. Composition: each 5 ml ampoule contains: ferric hydroxide in complex with sucrose equivalent to elemental iron 100 mg, water for injection ip q. S. Mechanism of action: following intravenous (iv) administration, iron sucrose is dissociated int... -
Product FOSAPORT?
Biocon offers a wide range of oncotherapeutic which includes fosaport. Mechanism of action: it is a prodrug of aprepitant and accordingly, its antiemetic effects are attributable to aprepitant. Aprepitant is a selective high-affinity antagonist of human substance p/neurokinin 1 (nk1) receptors. Aprepitant ... -
Product Genxtor?
Biocon offers a wide range of oncotherapeutic which includes genxtor?temsirolimus, an inhibitor of mtor, is an antineoplastic agent. Temsirolimus is a prescription medicine used to treat people with advanced kidney cancer (renal cell carcinoma or rcc) who have at least three of six prognostic risk factors.... -
Product GMAB? Plus
Biocon offers a wide range of metabolic which includes gmab plus. Composition: gla 100mg + methylcobalamin 1500mcg + ala 100mg + benfothiamine 100mg + elemental zinc 15mg - hard gelatin capsules. Mechanism of action: it is a multivitamin with mineral which acts as a secondary preventive agent and has a mul... -
Product HEPDOZE? 300mg TABS
Biocon offers a wide range of comprehensive care which includes hepdoze 300mg tabs. Composition: each film coated tablet contains: tenofovir disoproxil fumarate ip 300mg. Mechanism of action: tenofovir disoproxil (prodrug) is hydrolysed rapidly to tenofovir, subsequently phosphorylated by cellular kinases ... -
Product IMICELUM?
Biocon offers a wide range of comprehensive care which includes imicelum. Composition: each vial contains imipenem ip eq. To anhydrous imipenem - 500 mg, cilastatin sodium usp eq. To cilastatin - 500 mg, sodium bicarbonate ip added as buffer. Mechanism of action: the bactericidal activity of imipenem is fr... -
Product Insugen 30/70 Refil ?
Biocon offers a wide range of metabolic which includes insugen 30/70 refil ?. Composition: insulin biphasic, 30% soluble and 70% nph ? 3 ml cartridge of 100 iu/ml strength. In-use stability: 42 days/6 weeks. Mechanism of action: insulin opens the cell receptors for glucose molecules to enter, which in turn... -
Product Insugen 50/50 Refil ?
Biocon offers a wide range of metabolic which includes insugen 50/50 refil ?. Composition: insulin biphasic, 50% soluble and 50% nph ? 3 ml cartridge of 100 iu/ml strength. In use stability: 42 days/6 weeks. Mechanism of action: insulin opens the cell receptors for glucose molecules to enter, which in turn...
Biocon Limited resources (1)
-
News Viatris and Biocon score historic first for interchangeable biosimilar product
The new approval of Semeglee allows pharmacy-level substitution for Lantus across the US
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance